Trial document




drksid header

  DRKS00000191

Trial Description

start of 1:1-Block title

Title

Advance directives as an example for shared decision making in the General Practitioner practice

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

PPP

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

http://www.freiburger-patientenverfuegung.de

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

In Germany, an increasing number of people want to take preemptive measures concerning end-of-life decisions including, among others, preparing advance directives. An advance directive helps to determine the patient`s health care wishes at a time when he is no longer capable due to illness. The present study, which is funded by the German Federal Ministry of Education and Research (BMBF) is supposed to examine and improve the consultation about the completion of advance directives.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

Advance directives enable people to make medical decisions in case of future incoherence and as such constitute an important instrument for maintaining the patient`s autonomy. According to surveys, there are already 8 million completed advance directives in Germany. On September 1st, 2009, the first legal regulation regarding advance directives came into effect in Germany. Due to the implementation of said regulation and the complexity of the subject matter there is considerable public demand for further information. The goal of the present randomized controlled trial is to promote the patients` participation in medical decision making with regard to advance directives. This is to be achieved by training general practitioners in the field of shared decision making (SDM). SDM is a process of interaction between patient and doctor, which is aimed at reaching a mutually acceptable agreement based on shared information. Because of their experience in attending to chronically ill patients and their individual beliefs, expectations and concerns, general practitioners are specifically qualified to give advice on end-of-life decisions. The process is evaluated using three main factors:. "participation in medical decision making", "decisional conflicts" and "satisfaction with decision". They are measured using validated measuring instruments.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00000191
  •   2009/10/30
  •   [---]*
  •   yes
  •   Approved
  •   22/08, Ethik-Kommission der Albert-Ludwig-Universität Freiburg
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U1111-1111-9476 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   Consultation for Advance Directive
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Consultation for completing an Advance Directive after training of General Practitioners in Shared Decision Making
  •   Control group, treatment as usual
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Interventional
  •   [---]*
  •   Randomized controlled trial
  •   Single blind
  •   [---]*
  •   Other
  •   Other
  •   Parallel
  •   N/A
  •   [---]*
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Patient participation in medical decision making in context of completing Advance Directives.
Instrument: Shared Decision-Making Questionnaire
Measurement point: after consultation
Outcome measure: total score || Decisional conflicts in medical decision making
Instrument: Decisional Conflict Scale (DCS)
Measurement point: after consultation
Outcome measure: total score

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

Patient satisfaction with a decision
Instrument: Satisfaction with Decision Scale
Measurement point: after consultation
Outcome measure: total score

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • [---]*
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2009/11/01
  •   600
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Competent patients, sufficient knowledge of the German language.

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

Incompetent patients, insufficient knowledge of the German language.

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Bundesministerium für Bildung und Forschung
    • Mr.  Dr.  Volker  Wiesenthal 
    • Heinrich-Konen-Straße 1
    • 53227  Bonn
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up continuing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.